Associations between Diabetes Mellitus and Selected Cancers
Open Access
- 8 July 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 7476
Abstract
Cancer is one of the major causes of mortality and is the second leading cause of death. Diabetes mellitus is a serious and growing problem worldwide, and its prevalence continues to grow; it is the 12th leading cause of death. An association between diabetes mellitus and cancer has been suggested for more than 100 years. Diabetes is a common disease diagnosed among patients with cancer, and evidence indicates that approximately 8–18% of patients with cancer have diabetes, with investigations suggesting an association between diabetes and some particular cancers, increasing the risk for developing cancers such as pancreatic, liver, colon, breast, stomach, and a few others. Breast and colorectal cancers have increased from 20% to 30% and there is a 97% increased risk of intrahepatic cholangiocarcinoma or endometrial cancer. On the other hand, a number of cancers and cancer therapies increase the risk of diabetes mellitus. Complications due to diabetes in patients with cancer may influence the choice of cancer therapy. Unfortunately, the mechanisms of the associations between diabetes mellitus and cancer are still unknown. The aim of this review is to summarize the association of diabetes mellitus with selected cancers and update the evidence on the underlying mechanisms of this association.Keywords
This publication has 404 references indexed in Scilit:
- GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/ObesityJAMA Oncology, 2024
- Type 2 Diabetes and Colorectal Cancer RiskJAMA Network Open, 2023
- Management of Hepatocellular CarcinomaJAMA Surgery, 2023
- Incidence of Diabetes After Cancer DevelopmentJAMA Oncology, 2018
- Thiazolidinedione therapy and breast cancer risk in diabetic women: A systematic review and meta‐analysisDiabetes/Metabolism Research and Reviews, 2017
- Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With DiabetesJAMA, 2015
- Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c)Diabetes/Metabolism Research and Reviews, 2011
- Insulin analogues display IGF‐I‐like mitogenic and anti‐apoptotic activities in cultured cancer cellsDiabetes/Metabolism Research and Reviews, 2009
- Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes MellitusJAMA, 2008
- NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United StatesHepatology, 2002